The Benchmark Company initiated coverage on ImmunoPrecise Antibodies with a new price target

10/25/21 7:28:32 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

The Benchmark Company initiated coverage of ImmunoPrecise Antibodies with a rating of Buy and set a new price target of $12.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$IPA

Date	Price Target	Rating	Analyst
12/2/2022	$9.00	Buy	H.C. Wainwright
10/25/2021	$12.00	Buy	Benchmark
10/25/2021	$12.00	Buy	The Benchmark Company